Concerns Raised Over U.S. Military's New Testosterone Screening Initiative
Defense Secretary Pete Hegseth has announced a significant change in the U.S. military's health assessment protocol, introducing annual screenings for testosterone deficiency among service members aged 30 and older. This initiative aims to optimize health and combat readiness, as Hegseth stated in a video posted on X, emphasizing the importance of maintaining troops' physical and psychological well-being. Service members under 30 will have the option to request testing voluntarily. Those diagnosed with low testosterone may be offered testosterone replacement therapy (TRT), although participation in treatment is voluntary.
Testosterone is a crucial hormone that plays a role in regulating muscle mass, libido, mood, and energy levels. Its levels naturally decline with age, but low testosterone, known clinically as hypogonadism, can also result from various factors, including injury, lifestyle choices, and underlying health conditions. Hegseth believes that this program will keep military personnel at the forefront of readiness by ensuring their health.
However, experts have raised concerns regarding the necessity and implications of this screening policy. Dr. Philip Werthman, a board-certified urologist, argues that routine testosterone screening for all service members starting at age 30 lacks medical justification based on current evidence. Similarly, Dr. S. Adam Ramin cautions that testosterone blood tests may not provide useful information for younger men who do not exhibit symptoms of low testosterone.
The new policy integrates testosterone deficiency screening into an annual health visit known as a periodic health assessment for those aged 30 and older, while younger service members can opt for testing. If subsequent evaluations confirm testosterone deficiency, individuals can choose to receive TRT. Hegseth clarified that the goal is not to elevate testosterone levels beyond the natural range or to use it as a performance-enhancing substance, but rather to support longevity and maintain the biological foundation necessary for military effectiveness.
Despite these intentions, the details of the screening process remain unclear, and experts emphasize the importance of a rigorous protocol. Dr. Lawrence Jenkins points out that diagnosing testosterone deficiency requires more than a single low reading; it necessitates multiple low levels accompanied by symptoms. Testosterone levels can fluctuate throughout the day and may be influenced by various lifestyle factors, including sleep, diet, and physical activity. For military personnel, the demands of training and deployment can temporarily affect hormone levels.
Experts warn that without a comprehensive screening protocol, healthy service members might be subjected to unnecessary treatment. Dr. Ramin suggests that effective screening should include assessing symptoms and conducting physical exams rather than relying solely on blood tests.
TRT can alleviate symptoms for those with consistently low testosterone, but it carries risks that require careful consideration. Fertility concerns are particularly pressing for younger service members, as exogenous testosterone can suppress normal sperm production, potentially leading to infertility. While fertility may recover after discontinuation of treatment, the process is not guaranteed.
In addition to fertility issues, TRT can have other serious side effects, including increased risks of cardiovascular events, which have been a concern since 2015 when the FDA issued warnings about TRT. However, a recent trial led to recommendations for removing these warnings, indicating that TRT may not significantly increase the risk of heart attacks or strokes.
Prostate health is another critical factor, as testosterone replacement does not cause prostate cancer but may accelerate the growth of existing cancer. Therefore, screening for prostate cancer is essential before initiating TRT.
Experts agree that while testosterone plays a vital role in health, the key question remains whether routine screening for all service members over 30 will yield meaningful benefits. Dr. Werthman emphasizes the need for the government to demonstrate that the program improves military readiness while balancing the medical, reproductive, and ethical risks involved. Ultimately, targeted testing may be appropriate for service members exhibiting symptoms of low testosterone, allowing for a more individualized approach to treatment.




